Therapeutic Advances in Chronic Disease publishes the highest quality peer-reviewed research, reviews and scholarly comment in the drug treatment of all chronic diseases (excluding cancer). You can access the journal online for free at www.sagepub.com/taj.
The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers involved in the medical treatment of chronic disease, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest on research across areas of drug treatment of all major chronic diseases (excluding cancer, which is covered in Therapeutic Advances in Medical Oncology).
It publishes expert opinion reviews (including single-drug and drug class reviews), narrative reviews and analysis of published guidelines (as editorials or reviews). Original research manuscripts of well-designed trials are also welcomed that show drug or drug class efficacy in a particular disease or therapeutic area. The journal strongly encourages the submission of original research with positive or negative results.
The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees - a first editorial decision is generally reached within 3 weeks of submission. Online publication of articles occurs within 7 weeks from acceptance. Further information for contributors is provided on the back pages of each issue and online.
For all commercial sales and sponsorship enquiries, including advertising, reprints and supplements, please contact:
Commercial Sales Team, London, UK
Tel. +44 20 7336 1205
This journal is a member of the Committee on Publication Ethics (COPE).
Therapeutic Advances in Chronic Disease covers the drug treatment of all major chronic diseases (excluding cancer, which is covered in a sister publication).
It publishes guidance on which drugs to use and when (i.e. expert opinion reviews, narrative reviews, analysis of published guidelines (editorials or reviews). Single-drug reviews (including brief reviews of new drugs) and drug class reviews are also published with the aim of providing practically relevant information to the doctor group that treats such patients.
Original research manuscripts of well-designed trials are also welcomed that show drug or drug class efficacy in a particular disease.
The journal adheres to a blinded review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees - a first editorial decision is generally reached within 3 weeks of submission. Further information for contributors are provided on the back pages of each issue.
1. The purpose of the Journal is to publish (in the English language) editorials, reviews and original research articles, that have been judged worthy of publication by appropriate specialists and accepted by the Editor-in-Chief, on clinical studies relating to chronic disease. The Journal is for all professionals with special expertise or interest in chronic disease treatment and management, and is a forum for all views on this subject. The Editor-in-Chief welcomes articles of current interest on original research and reviews.
2. The Journal will be international in the sense that it will seek, wherever possible, to publish material from authors with an international reputation and articles that are of interest to an international audience.
3. In pursuit of the above the journal shall:
(i) draw on and include high quality work from the international community of scholars including those in the major countries of Europe, Australasia, the United States, other parts of the Americas, countries in the Third World and elsewhere with due representation for considerations of the readership. The Journal shall include work representing the major areas of interest in contemporary research in chronic disease.
(ii) avoid bias in favour of the interests of particular schools or directions of research or particular political or narrow disciplinary objectives to the exclusion of others;
(iii) ensure that articles are written in a terminology and style which makes them intelligible, not merely within the context of a particular discipline or abstract mode, but across the domain of relevant disciplines.
|Kathryn Abel||University of Manchester, UK|
|Bo Abrahamsen||Copenhagen University Hospital Gentofte, Hellerup, Denmark|
|Frazer H Anderson||Southampton University, UK|
|Riitta Antikainen||Oulu City Hospital, Finland|
|Jonathan Bayly||University of Derby, Derby, UK|
|Michael Berk||University of Melbourne, Australia|
|Michael Blackburn||University of Texas, USA|
|Xavier Calvet||Hospital de Sabadell, Spain|
|Rudolph Castellani||University of Maryland, USA|
|Gemma Casadesus||Case Western Reserve University, USA|
|Mario Cazzola||University of Rome "Tor Vergata", Rome, Italy|
|Pascal Chanez||University of the Mediterranian, France|
|Emma Clark||University of Bristol, Bristol, UK|
|Martin Connolly||University of Auckland, New Zealand|
|Leonardo M. Fabbri||University of Modena and Reggio Emilia, Italy|
|Serge Ferrari||Hopitaux Universitaires de Geneve, Switzerland|
|Andrea Fox||Chemical Abstracts Service, USA|
|Stephen Gallacher||Southern General Hospital, Scotland|
|Javier P. Gisbert||La Princesa University Hospital, Spain|
|Neil Gittoes||University Hospitals Birmingham, UK|
|Nicola A Hanania||Baylor College of Medicine, Houston, USA|
|Elaine Hylek||Boston Medical Center, Boston, MA, USA|
|Peter Joyce||Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand|
|Hyoung-gon Lee||Case Western Reserve University, Cleveland, OH, USA|
|Colleen Loo||St George Hospital, Australia|
|Ricardo Maccioni||University of Chile Medical School, Chile|
|Arduino Mangoni||Flinders University, Adelaide, Australia|
|Tahir Masud||Nottingham University, Nottingham, UK|
|Eugene McCloskey||University of Sheffield, UK|
|Terry McCormack||Whitby Medical Practice, UK|
|Andrew McIntosh||University of Edinborgh, UK|
|Paula Moreira||University of Coimbra, Portugal|
|Jaymin Morjaria||University of Hull, Cottingham, UK|
|Bjorn Moum||Faculty Div. Aker University Hospital, Norway|
|Anthony O'Conner||Adelaide and Meath Hospital, Ireland|
|Pierluigi Paggiaro||University of Pisa, Pisa, Italy|
|Sanjeev Patel||St Helier University Hospital, UK|
|Ruth Peters||Imperial College, London, UK|
|James B. Potash||Mood Disorders Centre, USA|
|Craig Ritchie||Imperial College London, UK|
|Shun Shinohama||Sapporo Medical University, Japan|
|Thomas Schulze||Georg-August-University Gvttingen , Germany|
|Massimo Tabaton||University of Genoa, Genoa, Italy|
|Lakshmi Yatham||University of British Columbia, Canada|
|Xiongwei Zhu||Case Western Reserve University, USA|
- Correspondence and online submission
- Publication categories
- Writing your manuscript
- Reference style
4.1 Corresponding author contact details
- Research ethics
- Publication statement
- Peer review statement
- Journal contributor’s publishing agreement
- Declaration of conflicting interests policy
- Funding Acknowledgement
- Informed consent
- After acceptance
10.2 E-Prints and complimentary copies
10.3 SAGE production
10.4 OnlineFirst publication
10.5 SAGE Choice